Tag: FDA stability

Effective Presentation of OOT and OOS Stability Trends for Regulatory Compliance In pharmaceutical manufacturing, establishing and maintaining compliance with regulatory expectations during stability studies is crucial for product lifecycle management.…

Addressing Temperature Excursions and Regulatory Expectations in Stability Studies Temperature excursions during pharmaceutical stability studies present a significant risk to product integrity. These deviations can lead to a deterioration of…

Creating an Inspection-Ready Stability Study File for Regulatory Audits The integrity of pharmaceutical products is paramount, and regulatory agencies have specific expectations surrounding stability studies to ensure this integrity over…

Addressing Common FDA 483 Observations in Stability Programs When regulatory agencies, like the FDA, issue 483 observations relating to stability programs, it signals significant concerns that can impact product quality…

Connecting Stability Specifications to Release Specifications in Pharmaceuticals In the pharmaceutical industry, ensuring product quality throughout its shelf life is critical for compliance and patient safety. One common challenge faced…

Understanding and Addressing Regulatory Expectations for Stability Studies In pharmaceutical manufacturing, the ability to demonstrate stability through reliable analytical methods is paramount. Regulatory agencies, including the FDA and EMA, have…